Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,344 public trials 2,835 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Recruiting

A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL

NCT05748171

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • St. Anna Kinderspital Vienna, Austria
  • Cliniques universitaires Saint-Luc Brussels, Bruxelles-capitale, Région de, Belgium
  • UZ Gent Ghent, Oost-vlaanderen, Belgium
  • UZ Leuven Leuven, Vlaams-brabant, Belgium
View all 68 locations
View Trial Details
Recruiting

A Study to Evaluate How Pozelimab + Cemdisiran Combination Therapy Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Whose Current Treatment is Not Working Efficiently

NCT07154745

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Hospital das Clinicas da FMRP USP Ribeirão Preto, São Paulo, Brazil
  • Faculdade de Medicina do ABC Santo André, São Paulo, Brazil
  • CISSS-CA Lévis, Quebec, Canada
  • Universita Cattolica del Sacro Cuore - Policlinico Universitario A. Gemelli Rome, Lazio, Italy
View all 19 locations
View Trial Details
Recruiting

A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)

NCT07194850

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +22 more
Locations
  • Centre Hospitalier Universitaire de Bordeaux Groupe Hospitalier Pellegrin Hopital des Enfants Bordeaux, France
  • Charite - Universitaetsmedizin Berlin - Campus Virchow-Klinikum (CVK) Berlin, Germany
  • Gaslini Children's Hospital Genoa, Italy
  • Fondazione IRCCS San Gerardo dei Tintori Monza, Italy
View all 20 locations
View Trial Details
Recruiting

A First-in-Human Safety and Efficacy Study of ALN-CFB, a Small Interfering RNA (siRNA) Targeting Complement Factor B, in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria With Persistent Anemia on a C5 Inhibitor

NCT07187401

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +6 more
Locations
  • Toronto General Hospital Toronto, Ontario, Canada
  • St. Vincent Hospital - The Catholic University of Korea Suwon, Gyeonggi-do, South Korea
  • The Catholic University of Korea, Seoul St. Mary's Hospital Seoul, South Korea
  • Seoul National University Hospital Seoul, South Korea
View Trial Details
Recruiting

A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes

NCT07203768

Conditions
Blood Platelet Disorders, Bone Marrow Diseases, Bone Marrow Neoplasms, +9 more
Locations
  • Mayo Clinic Rochester, Minnesota, United States
  • University Hospital Halle Halle, Germany
  • Hannover Medical School Hanover, Germany
  • University Clinic for Hematology, Oncology, Hemostaseology and Palliative Care Johannes Wesling Medical Center Minden, Germany
View all 24 locations
View Trial Details
Recruiting

Clinical Epidemiology in Contemporary Patients With Myelofibrosis.

NCT06533813

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Hematology Center after Prof.R.H. Yeolyan Yerevan, Armenia
  • University Hospital Halle Department of Hematology/Oncology Halle, Germany
  • University Medicine Hannover Hanover, Germany
  • University Clinic for Hematology, Oncology, Hemostaseology and Palliative Care Johannes Wesling Medical Center Minden UKRUB, University of Bochum Minden, Germany
View all 27 locations
View Trial Details
Recruiting

A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant

NCT05623020

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Jupiter Medical Center/Anderson Family Cancer Institute Jupiter, Florida, United States
  • MSK Basking Ridge Basking Ridge, New Jersey, United States
  • MSK Monmouth Middletown, New Jersey, United States
  • MSK Bergen Montvale, New Jersey, United States
View all 127 locations
View Trial Details
Recruiting

Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)

NCT07509151

Conditions
Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations
  • Research Site Adelaide, Australia
  • Research Site Fitzroy, Australia
  • Research Site Heidelberg, Australia
  • Research Site Nedlands, Australia
View all 30 locations
View Trial Details

Related conditions